In brief
Consumer NZ’s independent lab test of ten popular sunscreens in New Zealand revealed that 70 % fell below the SPF claimed on their labels, including an SPF 50 product that delivered only SPF 14. While all products passed broad‑spectrum requirements, the findings highlight a lack of mandatory re‑testing and spark a debate over regulatory oversight.
On 30 October Consumer NZ, a consumer‑advocacy organisation, announced that seven of the ten sunscreens it examined in its latest laboratory test failed to meet the sun‑protection factor (SPF) stated on their labels, with an SPF 50 product achieving only SPF 14.
The Xinhua News Agency reported on the New Zealand results, noting that despite all ten items passing broad‑spectrum safety standards, only three met their quoted SPF values. It also highlighted that the country’s high skin‑cancer rates underscore the importance of reliable sunscreen performance.
In a separate RNZ summary, the broadcaster relayed that the same Consumer NZ testing found the seven failures, adding that the products spanned a price range of $4 to $76 for 100 ml. The piece stressed the disparity between retail pricing and actual protection offered.
The NZ Herald reported a similar outcome: “Seven out of ten sunscreens failed to meet their SPF label claims, according to Consumer NZ testing.” It echoed the price range mentioned by RNZ and focused on consumer impact in a more general market‑centric tone.
Belinda Castles, a researcher with Consumer NZ, stated: “New Zealand has one of the highest skin cancer and melanoma rates in the world,” and emphasised the need for transparent, regular independent testing.
"Consumer NZ said there are no rules specifying how often sunscreens must be tested…previous investigations found some companies relied on test reports that were several years old."
All ten products examined met the broad‑spectrum protection frontier set by New Zealand’s testing standards, yet the discrepancy between advertised and actual SPF illustrates gaps in current regulatory frameworks that do not mandate periodic re‑testing of commercial sunscreen products.
The findings reiterate calls from consumer‑advocacy groups for statutory oversight ensuring that product labels reflect laboratory‑verified performance, a measure they argue would safeguard a population already vulnerable to high ultraviolet exposure.
Consumer NZ’s study remains the most recent independent data on the issue, and its authors maintain that without enforced re‑testing protocols, the risk of misleading product claims persists. The discussion continues across media outlets, reflecting divergent concerns over public health, corporate accountability, and regulatory policy.
"
